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1. Introduction 
In this chapter we present a new bisulfite-free method to detect and quantify DNA 
methylation and its application to the detection of imprinting disorders such as Prader-Willi 
(PWS) and Angelman (AS) syndromes. The method, called MethylMeter®, combines affinity 
separation of methylated and unmethylated DNA with CAP™ (Coupled Abscription®-
PCR), a new quantitative and sensitive signal generation process. In order to validate 
MethylMeter®, we analyzed samples from 54 patients diagnosed with Prader-Willi or 
Angelman syndromes, as well as samples from normal patients. Results were compared to 
the results obtained previously on these samples using bisulfite-based TaqMan® 
Methylation-Specific PCR (MS-PCR). Methylation detection with CAP was as accurate as 
with TaqMan, but was approximately 2000 times more sensitive. Methylated DNA was 
separated from unmethylated DNA with the use of magnetic beads bearing a new methyl-
CpG binding domain protein. The amount of the normally imprinted SNRPN promoter 
region present in the bound and unbound fractions was used to determine the relative 
amounts of methylated and unmethylated SNRPN promoter in the sample. The results were 
100% concordant with previous results generated with MS-PCR, but significantly less 
patient DNA and time were required to obtain results, which are more quantitative than 
MS-PCR. CAP based detection can be accomplished without fluorescent probes and in fewer 
cycles than with other PCR methods. Because methylated DNA is detected based on 
purification of methylated DNA, rather than on chemical conversion of unmethylated DNA, 
the disadvantages of bisulfite treatment are avoided. DNA is not degraded allowing 
analysis of samples as small as 1 ng. CAP primer development is not limited by the effects of 
reduced sequence complexity or a requirement to overlap primers with CpG sites in the 
target DNA.  
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1.1 Current methods for detecting DNA methylation in clinical samples 
The most commonly used methods for analyzing the DNA methylation levels of 
Differentially Methylated Regions (DMRs), such as CpG islands, and individual CpG sites, 
utilize treatment of patient DNA with the chemical bisulfite. Bisulfite converts 
unmethylated cytosine (C) residues to deoxyuracil (dU), while leaving methylated cytosine 
(MeC) unchanged. Upon PCR amplification of bisulfite-treated DNA, the MeC is copied to C 
and dU is copied to thymine (T). As a result, the retention of cytosine at a specific position 
indicates methylation. The modified DNA can then be analyzed by methods that detect the 
sequence difference between the amplified DNA generated from the methylated and 
unmethylated, bisulfite-treated starting material. 
In methylation-specific PCR (MSP), oligonucleotides that hybridize to a region on the DNA 
containing 1 or more potentially methylated CpG sites are added to the bisulfite-treated 
DNA. The oligonucleotides are designed to hybridize either to a DNA sequence 
corresponding to bisulfite-treated methylated DNA (still contains C), or to a sequence 
corresponding to bisulfite-treated unmethylated DNA (now contains dU), and PCR is 
performed in order to amplify the methylated and/or unmethylated target DNA (Herman, 
et al., 1996). Amplicons are analyzed by gel electrophoresis. Alternatively, fluorescence-
based quantitative real-time PCR can be performed on bisulfite-modified DNA (Eads, et al., 
2000; Zeschnigk, et al., 2004). Adaptations of quantitative real-time PCR utilize Taqman 
probes to generate a fluorescent signal or blocker oligonucleotides to prevent amplification 
of unmethylated DNA, resulting in increased assay sensitivity (Cottrell et al., 2004). 
Pyrosequencing is also utilized for methylation quantitation from bisulfite modified DNA  
(Tost et al., 2003). 
An advantage of bisulfite modification is that it is a widely used and established procedure 
and allows analysis of methylation at single CpG sites in the DNA. Some of the 
disadvantages to this assay are that bisulfite treatment of DNA can destroy a large 
percentage of the input DNA, resulting in limited sensitivity and the requirement for large 
amounts of DNA. Quality control assessment of bisulfite treated DNA is necessary before 
performing a detection assay to avoid misleading results. Extensive degradation can 
introduce sampling errors when few molecules are long enough to be amplified (Ehrich et 
al., 2007). Bisulfite treatment also creates DNA targets that are now very A-T rich, having 
converted unmethylated C to T, and this complicates the design of specific probes for PCR 
amplification. Bisulfite treatment remains the main source of variability for methylation 
detection, particularly in samples containing already degraded DNA, such as Formalin 
Fixed Paraffin Embedded (FFPE) tumor tissues. 
Other DNA methylation detection methods that do not use bisulfite rely on detection of 
methylated DNA by restriction enzyme analysis. The DNA is treated with either a MSRE 
(methylation-sensitive restriction enzyme) or a MDRE (methylation dependent restriction 
enzyme), amplified and then analyzed by microarray or gel analysis. MSREs are restriction 
enzymes, which cut at DNA only if the C in a CpG site is unmethylated. MDREs are 
restriction enzymes that require CpG methylation for cleavage. By treating DNA with either 
of these enzymes and subsequent comparison to a control sample, the methylation state of a 
DNA sample at that site can be determined. If digestion of a sample occurs after treatment 
with a MDRE, then the DNA is assumed to be methylated. Conversely, if the DNA is uncut 
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when treated with a MSRE, then this sample is also assumed to be methylated. By 
comparing the amount of cut vs. uncut DNA, the level of methylation can be estimated. A 
common read out for this type of methylation analysis is the subsequent amplification and 
fluorescent labeling of the digested DNA. The fragments can then be hybridized to a library 
microarray and analyzed (Lipmann et al., 2004) or simply resolved by electrophoresis. 
Quantitative real-time PCR is another mode of analysis (Ordway, et al., 2006). An advantage 
of MSRE/MDSE digestion is that no pretreatment of the DNA is necessary, although it is 
often performed in conjunction with bisulfite treatment of DNA in a procedure called 
COBRA (Xiong & Laird, 1997). Some disadvantages with this application are that it is a 
rather lengthy procedure and is dependent on the presence of specific restriction enzyme 
recognition sequences near the region of the target DNA. 
A final method that is commonly employed is chromatin immunoprecipitation (ChIP) by the 
use of antibodies against methyl binding proteins. Typically, cells are fixed and then 
methylated DNA is immunoprecipitated by the use of antibodies specific for methyl binding 
proteins. The resulting DNA is amplified, labeled and analyzed by hybridization in a 
microarray assay. The advantages of this method are that the assay can be performed from 
live cells with little or no DNA purification required. The assay also has increased 
sensitivity, as unwanted and contaminant DNA are removed prior to analysis. However, the 
procedure is very time-consuming, involves several steps and requires expensive reagents. 
Some assays may take as long as five days to complete.  
1.2 Imprinting disorder diagnosis by analysis of DNA methylation 
Genetic alterations in DNA methylation that affect imprinting play important roles in 
Prader-Willi syndrome (PWS) and Angelman syndrome (AS). The imprinted genes in 
chromosome 15 region 15q11.2-q13 that are associated with PWS and AS, including the 
SNRPN (small nuclear ribonucleoprotein peptide N) promoter region, are normally 
methylated and unexpressed in the maternal chromosome and unmethylated and expressed 
in the paternal chromosome. Loss of the unmethylated and expressed paternal copy by 
deletion, maternal uniparental disomy (UDP) or by imprinting errors, leaving the 
methylated and unexpressed maternal copy as the only version of the gene, is associated 
with PWS due to loss of paternal expression. Conversely, AS is associated with the loss of 
the maternal copy of 15q11.2-q13 which can occur through deletion, mutation in the 
maternally expressed gene Ubiquitin-protein ligase E3A (UBE3A) or paternal UDP. 
Methylation analysis of the SNRPN promoter is used to confirm diagnosis of PWS although 
methylation studies alone do not define the genetic basis for the diagnosis. A positive result 
of a methylation analysis leads to follow-up studies to define the genetic cause.  
The most commonly used diagnostic methylation tests for PWS and AS are MSP and Southern 
blot assays using methylation sensitive restriction enzymes (Glenn et al., 1996; Kubota et al., 
1997; Ramsden et al., 2010). Methylation-specific multiplex ligation dependent amplification 
(MS-MLA) has also been used to identify the methylation status of the PWS region and to 
detect copy number changes in the region (Nygren et al., 2005). The Southern blot assay and 
one version of MS-MLA depend on the use of methylation sensitive restriction enzymes which 
probe the methylation status of one or more CpG sites. Results can be affected by incomplete 
digestion of genomic DNA or rare SNPs affecting restriction sites (Ramsden et al., 2010). MSP 
and alternative versions of MS-MLA use bisulfite treated DNA.  
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1.3 Abscription® – Based signal amplification 
Abscription, short for Abortive Transcription, is a robust and isothermal signal amplification 
process that utilizes an RNA polymerase, called Abscriptase®, to generate thousands of 
specific short RNA oligonucleotides per minute from an artificial promoter called an 
Abortive Promoter Cassette (APC, Figure 1). Abscription exploits the natural phenomenon 
of abortive transcription during the initiation of transcription where RNA polymerases 
synthesizes large numbers of very short RNA molecules in the range of 2-12 nucleotides 
(Hsu et al., 2003; Hsu et al. 2006; Vo et al., 2003a; Vo et al., 2003b). Abortive transcription 
occurs very rapidly because RNA polymerase does not dissociate between rounds of short 
RNA synthesis and, if maintained in the abortive synthesis mode, will continue making 
short RNAs until nucleotide substrates are consumed. Each APC is designed to produce a 
short oligonucleotide of a different sequence and mass at turnovers of approximately 10,000 
per minute. By attaching an APC to a biomarker target and measuring the amount of 
abscript produced from the APC, Abscription can be use to give a quantitative measurement 
of the amount of the target present. The “aborted” transcripts, or abscripts, can be quantified 
by several methods, including mass spectrometry (MS), capillary electrophoresis (CE) and 
rapid Thin Layer Chromatography (rTLC).  
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Fig. 1. Signal generation by Abscription® (Abortive transcription) 
Abscription is catalyzed on a DNA template called an Abortive Promoter Cassette that 
encodes an RNA polymerase binding site and the start site for transcription. Abscripts are 
initiated with a dinucleotide complementary to the start site. Signal generation by Abscription 
exploits the natural phenomenon of abortive transcription which occurs during the initiation 
of transcription. Following promoter binding RNA polymerase temporarily synthesizes large 
numbers of RNA molecules in the range of 2-12 nucleotides. In normal transcription, the RNA 
polymerase undergoes a conformational change that allows promoter escape and entry into 
the processive elongation phase of the transcription cycle. Artificial promoters (APCs) and an 
abortive RNA polymerase, Abscriptase®, have been developed to trap the enzyme in the 
abortive phase and produce only abortive transcripts of specific sequence. 
The highest turnovers are produced by APCs encoding trinucleotides and their synthesis 
from a dinucleotide initiator and a single NTP (Figure 2). For example, the trinucleotide 
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abscript GpApG (GAG) is synthesized reiteratively by Abscriptase by an APC directed 
joining of the dinucleotide GpA and GTP. The sequences of the promoter and the initially 
transcribed segment have significant effects on the lengths and rates of synthesis of abortive 
transcripts (Hsu et al., 2006). Optimization of these sequences allowed the development of 
APCs that efficiently produce a variety of trinucleotide abortive transcripts (Hanna, 2006, 
2008, 2009). There are 64 different trinucleotides that can be made from the four standard 
nucleotides. APCs encoding over 20 of these trinucleotides have been developed.  
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Fig. 2. Synthesis of trinucleotide abortive transcripts 
Abortive transcripts can be limited to a uniform population of trinucleotides. In this 
example, a trinucleotide abscript is made exclusively by including a dinucleotide initiator 
(GpA) and a single nucleoside-triphosphate (GTP). A single polymerization step will 
produce a trinucleotide abortive transcript (GpApG) plus pyrophosphate (pp). The short 
RNA is expelled from the transcription complex and another is then made. GAG is 
produced at close to 10,000 copies per minute. Abscriptase is tolerant of modifications at 
both the 5’ position of the initiator (R1) and the 3’ position of the NTP (R3), allowing 
production of fluorescent or affinity tagged abscripts (such as biotin), if desired.  
1.4 Abscription® – Based biomarker detection  
Abscription is used to detect and quantify biomarkers in a sample by attaching an Abortive 
Promoter Cassette to that target (Figure 3). Once attached, Abscription is initiated and 
thousands of trinucleotides are generated per minute from the target. The amount of 
abscript produced can be quantified by analysis of the reaction by Liquid Chromatography 
– Mass Spectrometry (LC-MS). The substrates and trinucleotide product are separated by LC 
and then quantified by MS (Figure 4). The amount of abscript present is determined through 
the peak area off the MS. 
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Fig. 3. Measurement of Biomarkers by Abscription® 
 
Fig. 4. Analysis of trinucleotide abscripts by LC-MS  
Abortive Promoter Cassettes (APCs) are attached to biomarkers in a sample through 
chemical linkage to target specific antibodies (for proteins) or through single-stranded 
hybridization probes extending from the APCs for direct detection of nucleic acid targets. 
APCs also can be incorporated into nucleic acid targets during amplification procedures 
through the use of APC-primers as described in Fig. 7. Abscripts are then generated from 
the APC attached to the target by the APC-directed, enzymatic linkage of a dinucleotide 
initiator (N1pN2) to a single ribonucleoside-triphosphate (pppN3) by Abscriptase to produce 
a uniform population of trinucleotides and pyrophosphate. The amount of abscript is 
determined and used as a measure of the amount of target present. 
An Abscription product is quantified as the area under the trinucleotide chromatographic 
peak after fractionation of an Abscription reaction on a C18 column as shown in Part A for a 
reaction producing GpApG from GpA and GTP. GpA and GTP are separated from the 
trinucleotide product GpApG. The GTP passes rapidly through the column and is not 
shown in the elution profile in Part A. The amount of GpApG that elutes off of the column is 
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determined very quantitatively by analyzing the chromatographic output by MS in terms of 
mass/charge (m/z). Part B shows the mass spectrum for a portion of the GpApG peak. The 
doubly charged, singly charged and the sodium adduct of GpApG are quantified and 
summed across the peak to give the total abscript yield. 
1.5 Abscription – Based detection of DNA methylation: MethylMeter
®
 
MethylMeter is a bisulfite-free assay for the quantitative detection of DNA methylation that 
combines affinity separation of methylated and unmethylated DNA with a target and signal 
amplification process called CAP (Coupled Abscription-PCR). The process is extremely 
rapid and works even on badly degraded DNA. Although the application is demonstrated 
here for the detection of imprinting orders from blood samples, MethylMeter has also been 
used to analyze small changes in the methylation levels in tumor DNA isolated from 
formalin-fixed paraffin embedded (FFPE) tissues.  
1.5.1 MethylMagnet®: GST-MBD fusion protein with affinity for methylated CpG sites 
in DNA 
MethylMagnet proteins are versatile tools for the study of CpG methylation in DNA. These 
fusion proteins contain the methyl CpG binding domain (MBD) of the mouse MBD2 protein 
fused to the glutathione-S-transferase protein (GST) from S japonicum (Figure 5A). The MBD 
from the MBD2b protein was chosen because MBD2b has the highest affinity among the 
known methyl CpG binding proteins for methylated CpG sites and the lowest cross reactivity 
with unmethylated CpGs (Fraga et al., 2003). Additionally, there are no sequence context 
effects on MBD2 CpG recognition, as there are for MeCP2, which requires a run of A-Ts near a 
CpG site, therefore a greater number of mCpG sites will be recognized (Klose et al., 2005). The 
linker between the GST and the MBD domains contains a thrombin cleavage site, so the MBD 
domain can be separated from the GST, if desired, (Guan & Dixon, 1001) although the fusion 
protein is active for binding to glutathione, GST antibodies, and specifically to methylated 
DNA (Figure 5B). The GST group contains surface cysteines that can be chemically modified to 
add reporters or affinity tags. Both the fluorescein and biotin labeled fusion proteins also retain 
the binding properties of the unmodified protein (data not shown). 
The MethylMagnet protein is attached to glutathione modified magnetic beads and used to 
separate methylated DNA from unmethylated DNA in a genomic sample (Figure 6A). Intact 
genomic DNA should first be fragmented so that the CpG island of interest is physically 
separated from other regions on DNA that may be methylated, although MethylMagnet 
recognizes regions of CpG methylation density. Restriction with Mse I cuts DNA at the 
sequence TTAA and therefore is not affected by CpG methylation. DNA retrieved from 
formalin-fixed paraffin embedded (FFPE) tissues is already degraded and needs no 
restriction enzyme treatment before analysis. The fragmented DNA is incubated with the 
MethylMagnet protein which has been attached to glutathione magnetic beads. The DNA 
population will generally contain a mixture of methylated and unmethylated CpG sites. 
Methylated CpG islands will bind to the beads via interaction of the mCpG sites and the 
MBD domain. After capture, methylated DNA can be eluted from the magnetic beads 
several ways (Figure 6B). 
www.intechopen.com
 
DNA Methylation – From Genomics to Technology 
 
100 
 
 
Fig. 5. Binding of the GST-MBD protein to methylated DNA A. A glutathione-S-transferase 
(GST) fusion protein was constructed which contains GST attached to the methyl binding 
domain from mouse MBD2b. The GST allows the fusion protein or its complexes with 
methylated DNA to be isolated on glutathione agarose or glutathione magnetic beads and 
eluted intact with glutathione. The GST group further allows the eluted protein-DNA 
complexes to be immobilized to beads or microtiter plates or visualized with GST 
antibodies.B. MethylMagnet proteins have much higher affinity for DNA methylated on 
both strands, versus hemi-methylated (data not shown) or unmethylated DNA. Purified 
MethylMagnet (3 nM) was incubated with 100 fmoles of a biotinylated 550 bp p16 DNA 
fragment that was either fully methylated or unmethylated, or with no DNA. The 
biotinylated DNA target was immobilized to magnetic beads. The MethylMagnet protein 
was incubated with the immobilized DNA. After washing, bound MethylMagnet was 
detected with an anti-GST-HRP conjugate. The filled and unfilled bars represent duplicate 
measurements. Binding was very specific for the methylated DNA fragment. The signal 
from unmethylated DNA was no greater than that in the minus DNA control. 
1.5.2 MethylMeter™: Bisulfite-free, abscription based detection of methylated DNA 
The amount of a targeted CpG island or DMR in the methylated and unmethylated DNA 
fractions is quantitatively detected by a new method called CAP™, for Coupled 
Abscription®-PCR. CAP is a combination of target amplification by PCR and linear signal 
generation by Abscription. Figure 7 shows the strategy for detecting DNA methylation 
using MethylMagnet purification followed by CAP. Methylated and unmethylated DNA 
molecules are separated using magnetic bead bound GST-MBD protein. Methylated DNA 
attaches tightly to the beads due to cooperative binding with multiple MBD domains. The 
unmethylated fragments remain in the supernatant fraction. The methylated DNA is eluted 
from the beads and then both the supernatant fraction containing unmethylated DNA, and 
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the eluted fraction, containing methylated DNA are analyzed by CAP (Steps 2-3). CAP 
involves the amplification of both the methylated and unmethylated fragments (in separate 
tubes) using a conventional primer and a primer that contains a single-stranded abortive 
promoter cassette at its 5’ end. The APC is inactive for Abscription in the single-stranded 
form but becomes activated when it is converted into the duplex form during the 
amplification of the target. The PCR reaction is supplemented with Abscriptase® along with 
the dinucleotide and NTP substrates for abscript synthesis.  
 
Fig. 6. Separation of Methylated and Unmethylated DNA fragments with MethylMagnet® 
A. Genomic DNA is incubated with GST-MBD magnetic beads, leading to the 
immobilization of methylated fragments. Unmethylated DNA remains in solution and is 
recovered in the supernatant fraction of the binding reaction. B. The methylated DNA can be 
eluted from the bead several ways. Treatment with glutathione releases the GST-MBD DNA 
complex intact. Heat releases the DNA and denatured proteins from the beads. Proteinase K 
digests the proteins and releases the methylated DNA and peptide fragments. Thrombin 
will cleave in the linker between the GST and the MBD and will release the DNA as a 
complex with the MBD protein. And lastly, salt can be used to fractionate the methylated 
DNA based on methylation density, releasing the methylated DNA from the beads and 
leaving the GST-MBD protein behind. 
Each new amplicon now contains the APC and begins the reiterative synthesis of 
trinucleotide abscripts from each target. Because Abscription generates tens to hundreds of 
thousands of detectable trinucleotides per each amplicon, CAP is more sensitive than PCR 
alone, allowing detection of DNA methylation from very little DNA without fluorescent 
probes and in fewer cycles than with other PCR methods. Because methylated DNA is 
detected based on fractionation, rather than on chemical conversion, the disadvantages of 
bisulfite treatment are avoided. DNA is not degraded, allowing analysis of samples as small 
as 100 pg to 1 ng of genomic DNA. CAP primer development is not limited by the effects of 
reduced sequence complexity caused by bisulfite or a requirement to overlap primers with 
CpG sites, as in MS-PCR.  
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Fig. 7. Coupled Abscription®-PCR (CAP) based quantification of methylated DNA  
Fragmented DNA is separated into methylated (Eluted) and unmethylated (Supernatant) 
fractions with the use of magnetic beads bearing the MethylMagnet® protein. The protein 
binds to DNA fragments with high densities of methylated CpG dinucleotides. The presence 
of a targeted CpG island in either the methylated DNA fraction or the unmethylated fraction 
is measured by coupled Abscription-PCR (CAP, steps 2-3). Targets are amplified with a 
conventional primer (primer 1) matched with a primer encoding an Abortive Promoter 
Cassette (APC) at its 5’ end (primer 2). Conversion of the APC from a single-stranded form 
to a double-stranded promoter activates it for Abscription. Addition of Abscriptase, a 
dinucleotide initiator and a single NTP allows production of the encoded trinucleotide 
transcript. Abortive transcripts are detected by rapid Thin Layer Chromatography (rTLC, 
Figure 13) or by LC-MS. 
2. Results 
2.1 CAP assay for detection of methylated DNA   
In this study, the methylation status of a DNA segment from +234 to +539 nucleotides 
downstream from the start-site for SNRPN RNA variant 1 was analyzed to detect Prader-
Willi and Angelman Syndrome disorders from blood. Our strategy for detecting methylated 
DNA involves the separation of methylated DNA fragments from the unmethylated 
versions through the use of the 76 amino acid mouse methyl-CpG binding domain of MBD2 
fused to glutathione-S-transferase. The GST-MBD fusion protein, called MethylMagnet® 
was immobilized to glutathione magnetic beads to allow capture of methylated DNA 
fragments from a sample. After restriction, this promoter CpG island is part of a 1,237 
nucleotide MseI fragment. There are 62 MseI sites separating this segment from the next 
upstream CpG island, two MseI sites separating it from an immediately adjacent cluster of 
CpG sites which probably are part of the targeted CpG island, and 179 MseI sites before the 
next downstream CpG island. Experiments with synthetic DNAs showed that MBD2 
protein has a strong bias for densely spaced methylated sites. Synthetic DNAs with 4 
methylated CpG sites spaced on average 11 nt apart were fractionated with approximately 
50% efficiency. Those with six methylated CpG sites were bound quantitatively by GST-
MBD2 beads while DNAs having seven to twelve methylated sites spaced between 65 to 91 
nucleotides apart were bound very inefficiently (data not shown). Consequently, the linkage 
of widely spaced methylated CpGs that are not part of a CpG island following MseI 
digestion is unlikely to significantly influence the fractionation of the CpG island. 
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2.1.1 APC-primer development  
Signal generation in the CAP assay depends on the conversion of the inactive single-stranded 
APC into an active duplex form. Ideally this is accomplished only when a CAP primer is 
copied in the course of amplifying the target. The CAP assay is potentially vulnerable to 
primer dimer effects that would activate the APC in the absence of target DNA. Primer-primer 
interactions that lead to DNA synthesis copying the APC-primer from the downstream 
priming segment into the double-stranded and active APC cause strong background signals 
independent of target DNA. The SNRPN primers were tested for this possibility by 
performing PCR reactions with, or without DNA over a range of annealing temperatures.  
 
Primer Assay Primer Sequence (5’-3’) 
SNRPN F1 
qPCR, CAP (APC-primer, 
Abscript: GAG) 
TGCATAGGGATTTTAGGCGG 
SNRPN R1 qPCR, CAP CCGATCACTTCACGTACCTTC 
SNRPN F2 
CAP (APC-primer, 
Abscript: AUC) 
ACCTCCGCCTAAAATCCCTATG 
SNRPN R2 CAP CTTGCTGTTGTGCCGTTCTG 
Table 1. Primer sequences for CAP and TaqMan® assays 
Figure 8 shows the results for one of the two well-designed SNRPN promoter primer pairs 
that were used to analyze patient samples (Table 1). PCR reactions were carried out for 30 
cycles (2 cycles more than the standard protocol) followed by 30 min of Abscription. No 
background signal was seen over annealing temperatures from 62.9°C through 68.5°C 
(Figure 8A). Relatively strong abscript signals were generated in the presence of 1,000 copies 
of HeLa DNA at annealing temperatures 62.9°C and 64.9°C. Signal intensity fell at higher 
stringencies up to 68.5°C (Figure 8B).  
Primer validation included an assessment of amplification specificity in the presence of 
genomic DNA. Figure 8C shows an example for the SNRPN primer pairs that were used to 
analyze patient samples. PCR reactions were carried out with 3,000 copies of DNA from a 
normal patient sample and for 32 cycles in order to allow potential non-specific amplicons to 
be detected by agarose gel electrophoresis. Neither primer pair produced detectable non-
specific amplicons.  
2.2 Analysis of the SNRPN imprinting center in patient DNAs 
The MethylMeter® SNRPN assay was applied to the analysis of genomic DNA samples from 
38 patients whose diagnosis of PWS and AS were confirmed based on MS-PCR of the 
SNRPN imprinting center (Kubota et al., 1997; Kosaki et al., 1997). A collection of 16 normal 
samples was also analyzed. Purified DNA samples were exhaustively cleaved with MseI in 
overnight digestions to unlink the targeted SNRPN promoter region from neighboring CpG 
islands. Treated DNAs were fractionated with GST-MBD magnetic beads without prior 
purification to remove the restriction enzyme. MseI was inactivated by incubating the 
samples at 65°C for 20 min. The supernatants of the binding reactions containing 
unmethylated fragments were analyzed with the paired fractions containing methylated 
fragments that were eluted from the beads. The eluted fractions were in the same volume 
and in the same binding buffer as the supernatant fractions to eliminate potential PCR  
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Fig. 8. APC-primer pair specificity A. APC-SNRPN F2 and SNRPN R2 were tested for 
specific amplification of the SNRPN and their ability to synthesize abscripts by Coupled 
Abscription PCR at a series of increasing stringencies in the absence and presence of HeLa 
DNA. Samples were analyzed by LC-MS and the total amount of trinucleotide abscript 
made was measured and plotted as the relative peak area. Abscription signals in the absence 
of DNA indicate primer dimers or self priming events that activate the APC independently 
of a DNA target. B. Assays in the presence of DNA indicate the optimum annealing 
temperature that avoids self priming without unnecessarily sacrificing abortive transcript 
yield in the presence of DNA. C. The SNRPN APC-primer pairs APC-SNRPN F1-SNRPN R1 
(I) and APC-SNRPN F2-SNRPN-R2 (II) were used to amplify 3,000 copies of HeLa DNA for 
32 cycles. Samples were fractionated in a 2% w/v agarose gel followed by staining with 
ethidium bromide. Lane 1 shows the amplification reaction containing DNA. Lane 2 
represents the no-template control. Lane 3 shows a no-amplification control containing 
DNA but lacking Taq DNA polymerase. The expected amplicons contain 301 nucleotides 
(APC-SNRPN F1-R1) and 117 nucleotides (APC-SNRPN F2-R2)  
biases due to sample buffer differences. The fractions were subjected to 28 cycles with 2 
alternative sets of CAP primers with APCs that encoded either GAG or GUG. PCR reactions 
were followed by Abscription reactions for 15 to 30 min. The production of alternative 
abortive transcripts did not affect the results. The methylation status of a sample was 
determined by comparing abscript yields for the supernatant fraction (containing 
exclusively unmethylated SNRPN targets) and the eluted fraction (containing exclusively 
methylated SNRPN targets). 
Figure 9 shows results based on abscript detection by rapid Thin Layer Chromatography 
(rTLC) and Liquid Chromatography- Mass Spectrometry (LC-MS). Rapid TLC had the 
advantage of allowing rapid processing of multiple samples in parallel. Although the results 
are qualitative, the imprinting disorders lend themselves to a qualitative yes-no analysis 
since the samples are expected to contain either all methylated, all unmethylated or a 1:1 
ratio of both types of DNA. Figure 9A shows typical results for PWS (abscript GAG only in 
the methylated eluted fraction), AS (GAG only in the unmethylated supernatant fraction) 
and Normal (equal amounts of abscript GAG in both fractions). In all cases visual inspection 
of rTLC results for the 54 samples led to classifications of the samples in agreement with the 
more quantitative mass spectrometry assay (Figure 9B).  
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Fig. 9. CAP analysis of PWS and AS patient DNA 
Patient DNAs were separated with MethylMagnet into unmethylated (U) and methylated 
(M) fractions. Both fractions were amplified for the SNRPN imprinting center with CAP 
promoter primers and then were subjected to Abscription to produce the abscript GAG. Part 
A shows representative rTLC results for samples showing exclusively methylated SNRPN 
DNA (PWS), exclusively unmethylated SNRPN (AS) or an equal representation of both 
methylated and unmethylated DNA (Normal). GTP remains at the origin during the 
development of the chromatogram while GpA and GAG are separated from each other 
based on their differing rates of migration in the rTLC solvent. Part B shows a quantitative 
summary of all the CAP assays with LC-MS detection of the abscript signals. Normal 
samples (n = 16) showed 50.4% ± 2.5 methylation, PWS (Maternal pattern) samples (n = 25) 
showed 97.5% ± 4.2 methylation and AS samples (n = 13) showed 0.23% ± 0.31 methylation. 
MethylMagnet inputs were between 50 ng to 150 ng of DNA. 
Quantitative detection of methylated DNA was performed by LC-MS of diluted Abscription 
reactions. CAP reactions were fractionated by HPLC to separate the dinucleotide initiator from 
the trinucleotide abscript. The outflow from the HPLC column was injected into an 
electrospray ionization mass spectrometer (Waters LCT-Premier) to generate a 
chromatographic profile based on the mass/charge ratio of the abscript. The area of the 
abscript chromatographic peak is linearly related to the amount of abscript. Figure 9B and 
Table 2 show summary data for all the samples grouped into Normal, Maternal (methylated) 
and Paternal (unmethylated) patterns. The percent methylation was based on the abscript 
amount in the eluted fraction divided by the total abscript amount (the sum of the supernatant 
and eluted fractions). The results were highly reproducible in spite of the fact that the averages 
were based on multiple individuals. The large variance for the methylation level of the 
Paternal pattern was probably due to the statistics of sampling because the level of 
methylation indicates that the signals were probably generated from fewer than 5 molecules 
per CAP reaction based on estimates of the input amounts in calibrated CAP assays.  
The analysis of patient samples also indicated that nonspecific amplification was 
insignificant. A non-specific amplicon that is not linked to the SNRPN target would skew 
the results of the normal DNA samples away from a 1:1 ratio of methylated to unmethylated 
target DNA. If a hypothetical secondary target was methylated the paternal methylation 
pattern would show a proportionately high background of methylated signal. The opposite 
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bias would be seen in the maternal methylation pattern if the secondary target was 
unmethylated. As shown below, all of the patient samples fit one of the PWS, AS, or Normal 
methylation patterns without significant backgrounds (Table 2). The primer sequences that 
were the basis for the APC-primer pair SNRPN F2, R2 assay showed no apparent bias for 
unmethylated DNA over methylated DNA. For example the average amplification 
efficiencies over a 10°C annealing temperature range were 92.7% ± 7.0 (n = 11) for HeLa 
DNA and 92.9% ± 5.5 (n=4) for artificially methylated HeLa in TaqMan® assays. 
 
Methylation Pattern
Percent Methylation ± 
SD 
No. samples 95% confidence interval 
Normal 50.4 ± 2.5 16 1.23 
Maternal 97.5 ± 4.2 25 1.65 
Paternal 0.23 ± 0.31 13 0.17 
Table 2. Cumulative results for Prader-Willi/Angelman syndrome samples 
The reproducibility of the MethylMagnet fractionation method was evaluated by 
performing between 4 to 7 independent fractionations on DNA from 4 normal samples 
(Table 3). All of the fractionation runs gave good reproducibility with coefficients of 
variation (CVs) between 1.2% and 6.3%. The use of the alternative primers did not have a 
significant quantitative effect on the detection results. Sample #41 was analyzed in triplicate 
with APC-SNRPN F2, R2 that encoded AUC instead of GAG. The average methylation level 
was 49.8% ± 0.69 SD in agreement with the result for sample #41 in Table 3. The single-
blinded assignments of individuals to the 3 groups based on TLC and LC-MS were 100% 
concordant with earlier classification of the samples based on MS-PCR (data not shown). 
 
 1Cumulative
Normal 
Individual Normal Samples 
 #36 #39 #41 #53 
Percent Methylation 50.4 50.5 47.0 49.0 46.3 
SD 2.5 0.58 2.6 1.02 2.9 
CV 4.9% 1.2% 5.6% 2.1% 6.3% 
No. Fractionations 16 4 7 7 4 
Table 3. Reproducibility of MethylMagnet fractionation 1Data from Table 2 
2.3 Sensitivity of CAP verses TaqMan
®
 
Coupled Abscription-PCR involves the addition of Abscription, a linear signal amplification 
step, to PCR and is therefore much more sensitive than PCR alone. The relative sensitivity of 
the CAP assay was compared to a TaqMan PCR assay using the same SNRPN priming sites 
and PCR cycling conditions (Figure 10). Figure 10A shows a plot of Ct verses DNA amount 
for TaqMan amplification of HeLa DNA along with analogous plots for CAP. In the case of 
the CAP assay, the Ct-analog for the raw data is interpreted as the minimal cycle number 
required for detection of a particular input DNA copy number. These DNA amounts were 
not equivalent to limits of detection because the signals overshot the threshold for detection 
(an LC-MS signal of 100) by amounts ranging up to 549. The actual limits of detection at 
various cycles were calculated by extrapolating the lines relating LC-MS signals and DNA 
copy numbers to the detection threshold of 100 for each endpoint experiment. These 
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extrapolated DNA copy numbers were plotted with the associated end point cycles in 
Figure 10A (unfilled squares).  
 
 
Fig. 10. Sensitivity and dynamic range of CAP. A. Calibration curves were made with 
dilutions of HeLa DNA. The Ct values for detection of 10, 100, 1,000 and 10,000 copies are 
plotted for TaqMan PCR (open circles, Efficiency: 102%; r2: 0.999). The minimal cycle 
number at which a plotted DNA copy number can be detected is shown for a series of end-
point CAP experiments (filled rectangles, filled and open triangles). The limit of detection at 
a given CAP cycle number was calculated using curve fitting of the relationship between 
LC-MS signal and DNA copy number for each titration. The LOD was fixed to a signal 
intensity of 100 (unfilled squares represent the processed versions of the filled squares). 
Abscription reactions were for either 3 hr (squares) or for 15 min (triangles). B. HeLa DNA 
was titrated at the copy numbers indicated on the ordinate. Samples containing 3 to 1,000 
molecules were amplified for 28 PCR cycles followed by 30 min of Abscription (circles). 
Samples containing 1,000 to 100,000 molecules were amplified for 20 PCR cycles followed by 
15 min of Abscription (squares). Abscript signals were detected by LC-MS. Primer 
sequences used in the assay are listed in Table 1. 
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The sensitivity of the CAP assay could be adjusted with variations in the Abscription time 
following the PCR step. Overall a 3 hr Abscription reaction resulted in detection with a 
reduction of 11 cycles compared to the TaqMan assay. This translates to about a 2,000-fold 
improvement in sensitivity assuming 99.7% amplification efficiency. Sensitivity can also be 
estimated by determining the number of target copies at the detection threshold. The 
number of amplicons, Nt, at the Ct can be calculated by extrapolating the number of cycles 
to 0 in Figure 10A, where the x intercept is interpreted as the number of targets at the 
detection threshold (Rutledge & Cote, 2003). The qPCR assay produced an Nt of 6 x1011 
while the normalized CAP Nt was 4 x 107, a 2,650-fold improvement in sensitivity with a 3 
hr Abscription period. A 15 min Abscription time produced a 64-fold improvement in 
sensitivity over qPCR (Figure 10A). 
The dynamic range of the CAP assay could be made to extend over approximately 5 orders 
of magnitude by performing two CAP reactions at high and low cycle numbers as shown in 
Figure 10B. Samples with 10,000 and 100,000 DNA copies are prone to underestimates of 
DNA amount at high cycle numbers due to depletion of the Abscription reagents at 
moderate Abscription reaction times. The high end of the dynamic range is accurately 
quantified by performing 20 PCR cycles coupled with 15 min of Abscription. At the low end 
of the range (DNA input <1,000 copies), PCR is performed for 28 cycles followed by an 
Abscription time between 15 to 30 min. Following this strategy we were able to consistently 
quantify DNA amounts between 3 molecules to 100,000 molecules. 
2.4 Analysis of DNA methylation in other bodily fluids with MethylMeter 
MethylMeter is an extremely robust, sensitive, rapid and quantitative method to analyze 
even small changes in DNA methylation levels of differentially methylated regions. It works 
well and reproducibly in on DNA isolated from saliva and urine (Figures A and B), in which 
the normal methylation pattern is 50% methylated and 50% unmethylated. In addition, the 
process works well and reproducibly on DNA from FFPE tissue (Figure 11C), where 
bisulfite based methods often fail. 
 
Fig. 11. Detection of methylated DNA from saliva, urine, and FFPE tumor slides. A and B. 
Purified normal DNAs from saliva and urine sediments (50 ng) from the same individual 
were separated into methylated (M) and unmethylated (U) fractions with MethylMagnet. 
Methylated SNRPN CpG island was detected after 28 cycles of PCR and 15 min Abscription. 
C. FFPE DNA from normal lung was purified from 2 glass slides (10 µM thickness). SNRPN 
CpG island DNA was detected after 29 cycles of amplification and 30 min of Abscription.  
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2.5 MethylMeter: Comparison of results to bisulfite sequencing 
Although the results obtained by MethylMeter were 100% concordant with the results from 
MS-PCR, the method was further validated by analyzing SNRPN methylation in HeLa DNA 
(50%) with both MethylMeter and bisulfite sequencing. The region of SNRPN CpG island 
that was analyzed with bisulfite sequencing is shown in Figure 12.  
 
Fig. 12. Methylation of SNRPN Island: Method Comparison. The entire island probed by 
MethylMagnet is shown. The region that was sequenced is in the middle of the island and 
the CpG sites that were interrogated are numbered 1 to 24. The results of the bisulfite 
sequencing are shown under the sequence. A black circle indicates a methylated site. Sites 
that are used in MS-PCR analysis and some restriction enzyme based methods are shown. 
Note that site number 24, which was determined to be unmethylated by pyrosequencing, is 
the site used in the commercially available method EpiMark™ (NEN), which uses a 
restriction enzyme that cleaves differentially at this site based on CpG methylation, so this 
method would have incorrectly scored all of these samples as unmethylated. 
The MseI generated DNA segment from +234 to +539 nucleotides downstream from the 
start-site for SNRPN RNA variant 1 is shown. MseI cut HeLa DNA was assayed for 
methylation of this SNRPN CpG island, which is imprinted and 50% methylated in normal 
somatic tissues. The average percent methylated DNA determined by MethylMeter was 47.7 
± 2.9%. Unfractionated HeLa DNA was sent out for bisulfite sequencing of the SNRPN 
segment within the MseI fragment that was probed by MethylMeter. Filled circles are 
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methylated CpG sites (1-24). Five islands were scored as methylated and 5 unmethylated, 
identical to the MethylMeter results, which took 10X less DNA and far less time and money. 
Sites in this island that are probed by other common methods are also indicated. 
3. Materials and methods 
3.1 Patient samples 
Deidentified, purified DNAs from peripheral blood samples were obtained from the 
Molecular Genetics Laboratory, Children’s Hospital and Research Center at Oakland under 
IRB approval. The DNA samples were previously analyzed for the methylation status of the 
SNRPN imprinting center with MS-PCR (Kubota et al., 1997; Kosaki et al., 1997). 
3.2 Separation of methylated and unmethylated DNA with a Methyl CpG binding 
domain protein 
Patient DNAs were fragmented with restriction endonuclease MseI. MseI cuts segments 
between CpG islands at high frequencies but cuts CpG islands infrequently. Fragmented 
DNA (7.5-150 ng) samples were fractionated with the MethylMagnet® CpG DNA isolation 
kit following the instructions in the user manual (RiboMed, MM101K). DNA samples were 
diluted 5-fold into Binding Buffer and were incubated with 5 µl of GST-MBD magnetic 
beads for 1 hr at 22°C with shaking at 1,000 rpm in an Eppendorf Thermomixer. Supernatant 
fractions were recovered after collecting the beads with a magnet. The beads were washed 2 
times in 400 µl of Wash Buffer 2 with 5 min incubations at 22°C and shaking at 1,000 rpm. A 
third wash without incubation was performed with 400 µl of 10 mM Tris·HCl pH 8, 1 mM 
EDTA. Methylated DNAs were eluted from GST-MBD magnetic beads by incubation in 80% 
(v/v) Binding Buffer:18% (v/v) ultrapure water:2%(v/v) NEB buffer #4 at 80°C for 10 min 
with shaking at 1,000 rpm in an Eppendorf  Thermomixer. The supernatant and the eluted 
fractions of the binding reactions were saved for CAP analysis. 
3.3 Coupled Abscription-PCR (CAP) reaction 
PCR reactions were performed with Maxima Hot Start Taq DNA Polymerase (Fermentas) 
using the manufacturers reaction buffer [20 mM Tris·HCl pH 8.3 (25°C), 20 mM KCl, 50 
mM (NH4)2SO4] and 2 mM MgCl2, and 5% (v/v) DMSO. The dNTPS were added to final 
concentrations of 0. 2 µM each. CAP primers for the SNRPN promoter region were 
present at 1 µM each. Taq polymerase was added to 2 units/20 µl reaction. Inclusion of 
DMSO in the PCR reaction is essential to avoid amplification bias against methylated 
DNA. PCR conditions involved an initial denaturation step at 95°C for 30 sec, followed by 
28 cycles of 95° for 15 sec, 64°C for 15 sec and 72°C for 30 sec. A final elongation step was 
at 72°C for 5 min followed by indefinite incubation at 4°C. Abscription reactions were set 
up by supplementing 10 µl PCR reactions with 2 µl of an Abscription master mix 
consisting of 3.7 x Abscription buffer (1x buffer: 40 mM HEPES pH 7.5, 40 mM KCl, 10 
MgCl2), 6 mM dinucleotide initiator [(GpA, GpU or ApU, RiboMed I31, I34, I14], 6 mM 
NTP (either GTP or CTP) and 1 unit of thermostable Abscriptase (RiboMed MME-1). 
Abscription was performed in a thermocycler at 77.6°C for periods ranging from 15 min to 
3 hours.  
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3.4 Primer sequences 
All CAP promoter primers were based on 2 sets of primer sequences listed in Table 1. The 
SNRPN F1 and SNRPN F2 had 43 nucleotide single-stranded Abortive Promoter Cassettes 
(APCs) linked to their 5’ ends for the CAP assays. SNRPN F1 and SNRPN R1 were also used 
for qPCR experiments without the additional APC sequence. 
3.5 qPCR 
Conditions for TaqMan® qPCR reactions were essentially identical to the PCR portion of the 
CAP reactions except for the inclusion of ROX reference dye to 300 nM. Primers for the 
qPCR experiments did not include an APC extension. The primers SNRPN-F2 and SNRPN-
R2 targeted the promoter region of SNRPN transcript variant 1. A set of parallel CAP 
primers were derived from the same primer sequences (Table 1). The probe 
(5’AGGTATATTGGAGTGATTGTGGCGGG3’) was labeled at the 5’ end with 6-
carboxyfluorescene and at the 3’ end with Iowa Black®FQ (IDT). Titrations of HeLa DNA 
from 10 copies/PCR to 10,000 copies/PCR were amplified in 20 µl volumes in an ABI 7700 
Sequence Analyzer.  
3.6 Abscript analysis: HPLC-Mass Spectrometry (LC-MS) 
For high performance liquid chromatography-mass spectrometry (LC-MS) detection of 
abscripts, 10 µl of the CAP reaction was diluted into 20 µl of HPLC water in a 384 well plate. 
Volumes of 10 µl were injected into the LC-MS. 
3.7 Abscript analysis: Rapid Thin Layer Chromatography (rTLC) 
Analysis of abscripts by rTLC is both fast and extremely affordable. All that is needed is a 
small TLC developing tank and a handheld 254 nm light to visualize the products. 
Dinucleotides and trinucleotides migrate differently due to their varying polarities. 
Products are visualized by shining a 254 nm light on the TLC plate, which contains a 
fluorescent indicator. Nucleotides quench this fluorescence, resulting in a dark spot (UV 
shadowing). The TLC is photographed with a digital or CCD camera. Alternatively, 
fluorescent abscripts can be synthesized with labeled dinucleotides and then separated by 
TLC and visualized with a fluorescent imager or a 336 nm hand-held light (for fluorescein). 
Analysis by TLC involves three simple steps (Figure 13). 
For rTLC detection of abscripts in the patient samples, 1.5 µl of CAP reaction was spotted 1 
cm from the bottom edge of a 10 cm tall silica gel plate containing a UV-excitable 
fluorophore (Whatman, cat# 4420 222). The sample spots were air dried before placing the 
TLC plate in an air-tight rapid TLC solvent chamber (RiboMed cat# TC6-01) containing 100 
ml of freshly made rTLC solvent [6:3:1 (v/v) isopropanol :ammonium hydroxide: Activation 
buffer 1 (RiboMed, cat AB-1)]. The plate was submerged in solvent at a depth of 
approximately 5 mm, with the solvent just below the point at which the reaction sample was 
spotted on the plate. The plate was left in the tank for approximately 20 minutes to allow the 
solvent to flow upwards through the TLC plate by capillary action, causing separation of the 
components of the CAP reaction. When the solvent was approximately 1-2 cm from the top 
of the plate, it was removed from the tank. Developed plates were air dried and 
photographed with 254 nm UV-illumination.  
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Fig. 13. Rapid Thin Layer Chromatography (rTLC) Step 1 (A). Spot samples. Samples (1 to 
1.5 µl) are spotted directly onto precut TLC plates. No sample dye is required. The spotting 
template is designed for use with multi-channel pipettors on one side, allowing 21 samples 
per plate to be spotted. Even more samples can be analyzed by pipetting individually on the 
other side of the template, which can hold 32 samples. Step 2 (B): Put plates in the TLC 
developing tank. The TLC chamber holds 6 plates, so 120 samples plus 6 standards can be 
analyzed simultaneously using the multi-channel pipettor side. The entire process takes less 
than 1 hour. Up to 192 samples, or the equivalent of two 96 well plates, can be 
simultaneously processed when using the manual spotting template. Step 3: Irradiate the 
plate and to visualize the results. The TLC takes between 20 minutes to an hour to run, after 
which the plate is removed, air dried and visualized by UV shadowing, as shown below in 
(C). Spots can be quantified with the same imaging software used for gels. 
4. Conclusion 
Most methods for detecting methylated-CpG islands rely on chemical conversion of DNA by 
treatment with bisulfite. In conjunction with nucleotide sequencing this approach has the 
advantage that the methylation status of each CpG site in a targeted genomic region can be 
determined within sequence context. However, there are major disadvantages to bisulfite 
treatment especially when used with methods designed to determine the overall level of 
methylation in a genomic segment. Bisulfite conversion is carried out under relatively harsh 
conditions of low pH and high temperature that result in extensive degradation of the sample 
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DNA. This not only causes a requirement for relatively high DNA inputs, but also tends to 
place constraints on primer development limiting efficient amplification to small amplicons 
(Rutledge & Cote, 2003). Highly optimized commercial conversion kits work best with DNA 
samples in the range of 200 ng to 1 µg. Although samples in the range of 50 ng (15 genomic 
copies) can be treated, they cannot be used to generate quantitative data based on the effects of 
sampling statistics and losses during the post conversion clean-up (Rutledge & Cote, 
2003;Ehrich el al., 2007)  High cycle numbers or nested PCR are often needed to detect small 
amounts of bisulfite treated DNA. The reduction in sequence complexity caused by the 
conversion of cytosines to uracils places a further constraint on primer development by 
tending to homogenize the sequence compared to the untreated DNAs. 
Methylation specific PCR (MSP) methods based on bisulfite treated DNA rely on sets of 
primers and probes that overlap CpG sites. Discrimination based on primer 
complementarity to CpG verses TpG is vulnerable to false positive results due to incomplete  
conversion (Kristensen et al., 2008). Deep sequencing of DNA prepared by a commercial kit 
showed over 1% unconverted methyl-CpGs which potentially could be detected as false 
positives give the high sensitivity of MSP based methods pushed to high cycle numbers 
(Taylor et al., 2007). Heterogeneous patterns of methylation are not readily detected by MSP 
based methods because a consensus status must exist at all of the CpG sites encompassed by 
the primers and the probe. One must infer the status of an entire CpG island based on a 
small number of sites. A single consistently unmethylated CpG site will cause a false 
negative for a heavily methylated CpG island (Yegnasubramanian et al., 2006)    
The use of MBD proteins to fractionate methylated from unmethylated DNA fragments 
avoids the complications associated with bisulfite treatment. All of the CpG sites in a CpG 
island can contribute to the binding of a DNA by the MBD protein. Consequently it is not 
necessary to infer the overall methylation status based on a few CpG sites. The MBD2 
binding domain shows a strong bias in favor of DNA fragments containing multiple closely 
spaced methylated CpGs (Yegnasubramanian et al., 2006). This specific bias in favor of 
methylated CpG clusters has been exploited to survey the genome for methylated CpG 
islands (Serre et al., 2009).  
Because MBD based fractionation does not damage DNA, less sample is required than is 
needed for methods that rely on bisulfite treatment. We have successfully used MBD based 
DNA fractionation with as little as 1 ng of genomic DNA. DNA amounts in the microgram 
range can be processed by scaling-up the volume of MBD-magnetic beads in the binding 
reaction.  
The linkage of a linear signal amplification to the target amplification of PCR in the CAP 
method greatly increases assay sensitivity without adding complexity to assay development. 
Modest Abscription times between 15 min to 30 min allowed a reduction of between 6-7 cycles 
compared to TaqMan® assays on undamaged DNA. The CAP approach is expected to show a 
greater relative advantage in sensitivity compared to the application of TaqMan® assays to 
bisulfite treated DNA. Primer development for CAP assays is free of the constraints associated 
with bisulfite assays. CAP primers do not have to overlap with CpG sites nor do they have any 
constraints on primer spacing since no intervening probe sequence is needed. Care must be 
taken to avoid primer-dimer effects that lead to activation of the APC in the absence of DNA. 
Potential problems can be identified with conventional primer development software that 
shows homodimer- and heterodimer interactions. The potential for priming events can be 
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eliminated by changing nonconserved promoter sequences or by choosing a new reverse 
primer. Abscription provides an extremely sensitive assay to confirm the absence of primer-
dimer effects and to identify optimal stringency conditions.  
There are several options for abscript detection that depend on the nature of the targets. In 
the case of imprinting disorders where classification of samples is based on a simple yes or 
no result, a qualitative approach can be taken with rTLC. This method has the advantage 
that multiple samples can be processed rapidly in parallel allowing for greater through-put 
than LC-MS where samples are processed sequentially. All of the PWS AS samples gave 
unambiguous results that allowed them to be correctly classified based on visual inspection 
(Figure 9A). LC-MS is better suited for analysis of methylation in tumor cell DNA where 
quantitation is important or where it is important to monitor changes in methylation levels 
over time.  
One potential complication of the DNA fractionation-CAP approach is associated with the 
fragmentation of the DNA sample to unlink the region of interest from neighboring dense 
clusters of methylated CpGs. Incomplete digestion is usually not a problem because 
numerous MseI sites are typically situated between neighboring CpG islands. However in 
the case where a CpG island is closely linked to a methylated repetitive element it might be 
necessary to use an alternative restriction enzyme or shear the DNA to very small sizes. 
Analysis of very small fragments should be feasible with the CAP assay because there are no 
assay specific restrictions on primer placement or minimal spacing between primers. 
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